Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib.
| Publicado en: | Hematological Oncology Vol. 38; no. 4; pp. 607 - 611 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
Oct2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=146581626&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 146581626 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 02780232 O85 jtl: Hematological Oncology issn: 02780232 maglogo: Y pubinfo: dt: Oct2020 vid: 38 iid: 4 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 146581626 145831346 10.1002/hon.2765 146581626 ppf: 607 ppct: 4 formats: tig: atl: Favorable outcome of chronic myeloid leukemia co‐expressing e13a2 and e14a2 transcripts, treated with nilotinib. aug: au: Mulas, Olga Caocci, Giovanni Annunziata, Mario Martino, Bruno Luciano, Luigiana Castagnetti, Fausto Pregno, Patrizia Galimberti, Sara Albano, Francesco Orlandi, Ester M. Sgherza, Nicola Iurlo, Alessandra Bonifacio, Massimiliano Binotto, Gianni Gozzini, Antonella Bocchia, Monica Abruzzese, Elisabetta Fozza, Claudio Simula, Maria P. De Gregorio, Fiorenza affil: Department of Medical Sciences and Public Health, University of Cagliari, Businco Hospital, Cagliari, Italy sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|